Cannabinoid Modulation of Frontolimbic Activation and Connectivity during Volitional Regulation of Negative Affect

Neuropsychopharmacology

Volumn 41, Issue 7, 2016, Pages 1888-1896

  Gorka, Stephanie M ^a   Phan, K Luan ^a,b   Lyons, Maryssa ^c   Mori, Shoko ^c   Angstadt, Mike ^c   Rabinak, Christine A ^c,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Jesse Brown Medical Center   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRAHYDROCANNABINOL; CANNABINOID RECEPTOR AGONIST; DRONABINOL; OXYGEN;

ADULT; AFFECT; AMYGDALA; ARTICLE; COGNITION; CONNECTOME; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMOTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; LIMBIC CORTEX; MALE; NORMAL HUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; AROUSAL; BLOOD; BRAIN MAPPING; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG EFFECTS; IMAGE PROCESSING; MULTICENTER STUDY; NERVE TRACT; NEUROPSYCHOLOGICAL TEST; YOUNG ADULT;

ADULT; AFFECT; AMYGDALA; AROUSAL; BRAIN MAPPING; CANNABINOID RECEPTOR AGONISTS; COGNITION; DOUBLE-BLIND METHOD; DRONABINOL; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PREFRONTAL CORTEX; YOUNG ADULT;

EID: 84953292934     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.359     Document Type: Article

References (45)

1. Ballard ME, Bedi G, de Wit H (2012). Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images. J Psychopharmacol 26: 1289-1298.
2. Banks SJ, Eddy KT, Angstadt M, Nathan PJ, Phan KL (2007). Amygdala frontal connectivity during emotion regulation. Soc Cogn Affect Neurosci 2: 303-312.
3. Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, McGuire PK (2012a). Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies. Curr Pharm Des 18: 5045-5054.
4. Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, Fusar-Poli P et al (2012b). Induction of psychosis by delta-9-tetrahydrocannbinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry 69: 27-36.
5. Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T et al (2010). Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35: 764-774.
6. Bitencourt RM, Pamplona FA, Takahashi RN (2008). Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol 18: 849-859.
7. Buhle JT, Silvers JA, Wager TD, Lopez R, Onyemekwu C, Kober H et al (2013). Cognitive reappraisal of emotion: A meta-analysis of human neuroimaging studies. Cereb Cortex 24: 2981-2990.
8. Chhatwal JP, Davis M, Maguschak KA, Ressler KJ (2005). Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 30: 516-524.
9. Chhatwal JP, Ressler KJ (2007). Modulation of fear and anxiety by the endogenous cannabinoid system. CNS Spectr 12: 211-220.
10. Curran VH, Brignell C, Fletcher S, Middleton P, Henry J (2002). Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology 164: 61-70.
11. de Oliveira Alvares L, Pasqualini Genro B, Diehl F, Molina VA, Quillfeldt JA (2008). Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. Neuroscience 154: 1648-1655.
12. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT et al (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558-1572.
13. Diekhof EK, Geier K, Falkai P, Gruber O (2011). Fear is only as deep as the mind allows: a coordinate-based meta-analysis of neuroimaging studies on the regulation of negative affect. Neuroimage 58: 275-285.
14. Eggan SM, Lewis DA (2007). Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 17: 175-191.
15. Erk S, Mikschl A, Stier S, Ciaramidaro A, Gapp V, Weber B, Walter H (2010). Acute and sustained effects of cognitive emotion regulation in major depression. J Neurosci 30: 15726-15734.
16. First MB, Spitzter RL, Gibbon M, Williams JB (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition (SCID-I/NP). Biometrics Research Department, New York State Psychiatric Institute: New York.
17. Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S et al (2010). Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol. Int J Neuropsychopharmacol 13: 421-432.
18. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R et al (2009). Distinct effects of Δ9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 66: 95-105.
19. Gorka SM, Fitzgerald DA, de Wit H, Phan KL (2015). Cannabinoid modulation of amygdala subregion functional connectivity to social signals of threat. Int J Neuropsychopharmacol 18: 1-6.
20. Gross JJ (1998). Antecedent-and response-focused emotion regulation: divergent consequences for experience, expression, and physiology. J Pers Soc Psychol 74: 224-237.
21. Gross JJ (2001). Emotion regulation in adulthood: timing is everything. Curr Dir Psychol Sci 10: 214-219.
22. Gross JJ (2002). Emotion regulation: affective, cognitive, and social consequences. Psychophysiology 39: 281-291. Gross JJ (ed). Handbook of Emotion Regulation. Guilford Publications, 2013.
23. Gruber SA, Rogowska J, Yurgelun-Todd DA (2009). Altered affective response in marijuana smokers: an FMRI study. Drug Alcohol Depend 105: 139-153.
24. Lang PJ, Bradley MM, Cuthbert BN (2008). International Affective Picture System (IAPS): Affective Ratings of Pictures and Instruction Manual, Technical Report A-8. University of Florida: Gainesville, FL.
25. Lieberman MD, Cunningham WA (2009). Type I and type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci 4: 423-428.
26. Lutz B (2009). Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol 9: 46-52.
27. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. In: Pertwee RG (ed). Cannabinoids. Springer: Berlin Heidelberg, 2005, pp 229-325.
28. Marsicano G,Wotjak CT, Azad SC, Bisogno T, Rammes G, CascioMG et al (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534.
29. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2002). Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology 159: 379-387.
30. McDonald J, Schleifer L, Richards JB, de Wit H (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28: 1356-1365.
31. Ochsner KN, Bunge SA, Gross JJ, Gabrieli JDE (2002). Rethinking feelings: an fMRI study of the cognitive regulation of emotion. J Cogn Neurosci 14: 1215-1229.
32. Ochsner KN, Gross JJ (2005). The cognitive control of emotion. Trends Cogn Sci 9: 242-249.
33. Ochsner KN, Silvers JA, Buhle JT (2012). Functional imaging studies of emotion regulation: a synthetic review and evolving model of the cognitive control of emotion. Ann NY Acad Sci 1251: E1-E24.
34. Phan KL, Angstadt M, Golden J, Onyewuenyi I, Popovska A, de Wit H (2008). Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci 28: 2313-2319.
35. Phan KL, Fitzgerald DA, Nathan PJ, Moore GJ, Uhde TW, Tancer ME (2005). Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study. Biol Psychiatry 57: 210-219.
36. Phan KL, Sripada CS. Emotion regulation. In: Armony J, Vuilleumier P (eds). The Cambridge Handbook of Human Affective Neuroscience. Cambridge University Press: Cambridge, UK, 2013, pp 375-400.
37. Rabinak CA, Angstadt M, Lyons M, Mori S, Milad MR, Liberzon I et al (2014). Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans. Neurobiol Learn Mem 113: 125-134.
38. Rabinak CA, Angstadt M, Sripada CS, Abelson JL, Liberzon I, Milad MR et al (2013). Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology 64: 396-402.
39. Rabinak CA, Sripada CS, Angstadt M, de Wit H, Phan KL (2012). Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect. J Neural Transm 119: 701-707.
40. Richards JM, Gross JJ (2000). Emotion regulation and memory: the cognitive costs of keeping one's cool. J Pers Soc Psychol 79: 410-424.
41. Stenger VA, Boada FE, Noll DC (2000). Three-dimensional tailored RF pulses for the reduction of susceptibility artifacts in T∗ 2-weighted functional MRI. Mag Reson Med 44: 525-531.
42. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15: 273-289.
43. United Nations Office on Drugs and Crime (2012). World Drug Report 2012. United Nations: New York, USA.
44. Urry HL, van Reekum CM, Johnstone T, Kalin NH, Thurow ME, Schaefer HS et al (2006). Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. J Neurosci 26: 4415-4425.
45. Walter B, Blecker C, Kirsch P, Sammer G, Schienle A, Stark R et al (2003). MARINA: an easy tool for the creation for MAsks for Region of INterest Analyses. Paper presented at the 9th International Conference on Functional Mapping of the Human Brain, New York, NY.